TickerFacts.

Lantheus Holdings, Inc. (LNTH): Net Income

Annual figures by period end, from SEC filings.

$233.56M
Year ended 2025-12-31
$275.31M
Trailing 12 months to 2026-06-30
+102.6%
3-year compound annual growth
$326.66M2017-12-31: $123.39M2018-12-31: $40.52M2019-12-31: $31.67M2020-12-31: -$13.47M2021-12-31: -$71.28M2022-12-31: $28.07M2023-12-31: $326.66M2024-12-31: $312.44M2025-12-31: $233.56M$233.56M
2017-12-31 Net Income (USD) 2025-12-31
Period endedNet IncomeChange YoYSource filing
2025-12-31$233.56M-25.2%2026-02-26, From 2025-01-01
2024-12-31$312.44M-4.4%2026-02-26, From 2024-01-01
2023-12-31$326.66Mn/m2026-02-26, From 2023-01-01
2022-12-31$28.07Mn/m2025-02-26, From 2022-01-01
2021-12-31-$71.28Mn/m2024-02-22, From 2021-01-01
2020-12-31-$13.47Mn/m2023-02-23, From 2020-01-01
2019-12-31$31.67M-21.8%2022-02-24, From 2019-01-01
2018-12-31$40.52M-67.2%2021-02-25, From 2018-01-01
2017-12-31$123.39Mn/a2020-02-25, From 2017-01-01

Net Income at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedNet IncomeChange YoY
Lantheus Holdings, Inc. (LNTH)2025-12-31$233.56M-25.2%
QuidelOrtho Corp (QDEL)2025-12-28-$1.13Bn/m
Neogen Corp (NEOG)2026-05-31-$7.90Mn/m
Myriad Genetics Inc (MYGN)2025-12-31-$365.90Mn/m
Idexx Laboratories Inc (IDXX)2025-12-31$1.06B+19.3%
Intellia Therapeutics, Inc. (NTLA)2025-12-31-$412.69Mn/m
Alpha Teknova, Inc. (TKNO)2025-12-31-$17.26Mn/m
Immucell Corp (ICCC)2025-12-31-$1.04Mn/m
Aspira Women's Health Inc. (AWHL)2025-12-31-$12.78Mn/m

Compare LNTH, QDEL, NEOG, MYGN side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗